Skip to main content
Premium Trial:

Request an Annual Quote

Invitrogen and ReliaGene Technologies to Develop Forensic Test to Identify Male DNA

NEW YORK, Sept. 22 (GenomeWeb News) - Invitrogen and ReliaGene Technologies, a human identification laboratory, will co-develop a product to detect Y-chromosome DNA in forensic samples, New Orleans-based ReliaGene said today.


The companies plan to combine ReliaGene's Y-Detect male-specific DNA recognition technology with Invitrogen's ChargeSwitch forensics DNA purification kit to screen forensic samples for the presence of male DNA, in particular samples from sexual assaults.


The resulting product, Y-Screen, promises to reduce false negative results, according to ReliaGene, and is scheduled to be released in the first quarter of 2006.

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.